RETRACTED: Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia / reperfusion injury
Open Access
- 1 October 2020
- journal article
- retracted article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 130, 110604
Abstract
No abstract availableKeywords
Funding Information
- National Science and Technology Development Agency
- National Research Council of Thailand
- Alvin J. Siteman Cancer Center
- Thailand Research Fund (RSA6180056)
- Chiang Mai University
This publication has 39 references indexed in Scilit:
- Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin‐resistant ratsBritish Journal of Pharmacology, 2013
- The Role of PPARα in Metformin-Induced Attenuation of Mitochondrial Dysfunction in Acute Cardiac Ischemia/Reperfusion in RatsInternational Journal of Molecular Sciences, 2012
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Toxicity and toxicokinetics of metformin in ratsToxicology and Applied Pharmacology, 2010
- AMP-Activated Protein Kinase Activation during Cardioplegia-Induced Hypoxia/Reoxygenation Injury Attenuates Cardiomyocytic Apoptosis via Reduction of Endoplasmic Reticulum StressMediators of Inflammation, 2010
- Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine ReceptorJournal of Cardiovascular Pharmacology, 2009
- Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart FailureCirculation Research, 2009
- Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated SignalingDiabetes, 2008
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998